Gland FDA Monday, October 26, 2026 +0.70 Positive

FDA Approves EPINEPHRINE — Gland Pharma Limited

Gland Pharma Limited has received final approval from the FDA to manufacture and market generic epinephrine for intramuscular use. This addition to the regulatory portfolio positions the company to capture a significant share of the high-demand emergency injectable market.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed